Lupin has received USFDA approval for its Abbreviated New Drug Application ANDA Efinaconazole Topical Solution 10Percentage to market a generic equivalent of Jublia Topical Solution 10Percentage of Bausch Health Americas Inc The product will be manufactured at Lupins facility in Pithampur India Efinaconazole Topical Solution 10Percentage RLD Jublia Topical Solution 10Percentage had estimated annual sales of USD 274 million in the US QVIA MAT December 2021
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
